UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029199
Receipt number R000033377
Scientific Title Open study of ORM
Date of disclosure of the study information 2017/09/20
Last modified on 2018/09/28 14:21:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Open study of ORM

Acronym

Open study of ORM

Scientific Title

Open study of ORM

Scientific Title:Acronym

Open study of ORM

Region

Japan


Condition

Condition

periodontal disease

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the efficacy and safety of ORM in periodontal disease patients

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Measurement of periodontal disease index at week4 .Taking photography of oral cavity at week4.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

administer ORM twice daily for 4weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

64 years-old >=

Gender

Male and Female

Key inclusion criteria

-Patients aged 20 to 64 years on the day of signing the informed consent
-Mild to moderate periodontal disease patients

Key exclusion criteria

-Patients who have systemic diseases thought to affect evaluation of this study
-Patients who have serious oral diease thought to affect evaluation of this study
-Patients who smoke

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshio Shimabukuro

Organization

Shimabukuro Dental Clinic

Division name

-

Zip code


Address

1-5-6Tezukayamahigashi, Sumiyoshi, Osaka, Japan

TEL

06-6675-0418

Email

smbk@dental.email.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masahiko Kawai

Organization

ROHTO pharmaceutical CO.,LTD

Division name

Clinical development group Development & Planning office

Zip code


Address

6-5-4Kunimidai, Kizugawa, Kyoto, Japan

TEL

0774-71-8820

Homepage URL


Email

kawaim@rohto.co.jp


Sponsor or person

Institute

ROHTO pharmaceutical CO.,LTD

Institute

Department

Personal name



Funding Source

Organization

ROHTO pharmaceutical CO.,LTD

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 09 Month 20 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 09 Month 11 Day

Date of IRB


Anticipated trial start date

2017 Year 09 Month 25 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 09 Month 20 Day

Last modified on

2018 Year 09 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033377


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name